FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

Data Compilation
#PharmaFlow

Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

Stock Recap
#PipelineProspector

Loratadine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 23 USDMF, 11 CEP/COS, 6 JDMF, 15 EU WC, 17 KDMF, 13 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

288 FDF Dossiers, 61 FDA Orange Book, 112 Europe, 13 Canada, 5 Australia, 42 South Africa, 55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG, TABLET, EXTENDED RELEASE;ORAL - 10MG;240MG, SYRUP;ORAL - 1MG/ML, TABLET, ORALLY DISINTEGRATING;ORAL - 10MG, CAPSULE;ORAL - 10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 5 Rochem International Inc, 23 SPI Pharma, 20 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 28 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 43 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

99 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 45 Thickeners and Stabilizers, 37 Direct Compression, 35 Taste Masking, 33 Granulation, 32 Disintegrants & Superdisintegrants, 30 Solubilizers, 27 Controlled & Modified Release, 27 Parenteral, 25 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 24 Film Formers & Plasticizers, 22 Topical, 15 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 29 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 Regulatory FDF Prices

16 Regulatory FDF Prices

MARKET PLACE

44 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 37 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
29/01/2026	Alivus Life Sciences	India	Glenmark Life Sciences Limited	66039-805	Loratadine	2006-05-02	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)
29/01/2026	Fagron Group	Netherlands	Fagron Inc	51552-1210	Loratadine	2011-10-31	2027-04-30	BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING	POWDER (1g/g)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Loratadine

Loratadine

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers

23 USDMF

11 CEP/COS

6 JDMF

15 EU WC

17 KDMF

13 NDC API

26 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

288 FDF Dossiers

61 FDA Orange Book

112 Europe

13 Canada

5 Australia

42 South Africa

55 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG

TABLET, EXTENDED RELEASE;ORAL - 10MG;240MG

SYRUP;ORAL - 1MG/ML

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG

CAPSULE;ORAL - 10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

5 Rochem International Inc

23 SPI Pharma

20 DKSH

1 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

8 Kirsch Pharma

1 Panvo Organics

4 ACG Worldwide

11 Actylis

2 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

28 BASF

1 Bioplus Life Sciences

2 CD Formulation

1 Clariant

11 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

5 Ideal Cures

5 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

43 Roquette

14 Seppic